DK1601361T3 - Pyridylsulfonamidopyrimidiner til behandling af iabetisk nefropati - Google Patents

Pyridylsulfonamidopyrimidiner til behandling af iabetisk nefropati

Info

Publication number
DK1601361T3
DK1601361T3 DK04716605T DK04716605T DK1601361T3 DK 1601361 T3 DK1601361 T3 DK 1601361T3 DK 04716605 T DK04716605 T DK 04716605T DK 04716605 T DK04716605 T DK 04716605T DK 1601361 T3 DK1601361 T3 DK 1601361T3
Authority
DK
Denmark
Prior art keywords
treatment
nephropathy
pyridylsulfonamidopyrimidines
iabetic
zero
Prior art date
Application number
DK04716605T
Other languages
Danish (da)
English (en)
Inventor
Jessica Mann
Original Assignee
Speedel Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Pharma Ag filed Critical Speedel Pharma Ag
Application granted granted Critical
Publication of DK1601361T3 publication Critical patent/DK1601361T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DK04716605T 2003-03-06 2004-03-03 Pyridylsulfonamidopyrimidiner til behandling af iabetisk nefropati DK1601361T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03100549A EP1454625A1 (en) 2003-03-06 2003-03-06 Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies
PCT/EP2004/050242 WO2004078104A2 (en) 2003-03-06 2004-03-03 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy

Publications (1)

Publication Number Publication Date
DK1601361T3 true DK1601361T3 (da) 2008-08-25

Family

ID=32799012

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04716605T DK1601361T3 (da) 2003-03-06 2004-03-03 Pyridylsulfonamidopyrimidiner til behandling af iabetisk nefropati

Country Status (27)

Country Link
US (2) US20060094731A1 (el)
EP (2) EP1454625A1 (el)
JP (1) JP4737686B2 (el)
KR (1) KR101099189B1 (el)
CN (1) CN100453081C (el)
AT (1) ATE395063T1 (el)
AU (2) AU2004216858B2 (el)
BR (1) BRPI0408082A (el)
CA (1) CA2517930C (el)
CY (1) CY1108241T1 (el)
DE (1) DE602004013734D1 (el)
DK (1) DK1601361T3 (el)
EC (1) ECSP056060A (el)
ES (1) ES2305737T3 (el)
HK (1) HK1083761A1 (el)
HR (1) HRP20050860A2 (el)
IL (1) IL170626A (el)
MX (1) MXPA05009478A (el)
NO (1) NO20054148L (el)
NZ (1) NZ542155A (el)
PL (1) PL1601361T3 (el)
PT (1) PT1601361E (el)
RS (1) RS20050683A (el)
SI (1) SI1601361T1 (el)
UA (1) UA82087C2 (el)
WO (1) WO2004078104A2 (el)
ZA (1) ZA200507122B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1595880A1 (en) * 2004-05-13 2005-11-16 Speedel Pharma AG Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
CN101257947A (zh) * 2005-09-12 2008-09-03 斯皮德尔药品公司 用于预防血管移植失败的吡啶磺酰胺基-嘧啶类
IN2013CN00342A (el) 2010-06-17 2015-07-03 Nitto Denko Corp
CN109260164A (zh) * 2018-10-07 2019-01-25 威海贯标信息科技有限公司 一种阿伏生坦片剂组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2184712A1 (en) * 1994-03-17 1995-09-21 Marc De Gasparo Treatment of diabetic nephropathy with valsartan
CA2162630C (en) * 1994-11-25 2007-05-01 Volker Breu Sulfonamides
DE69626986T2 (de) * 1995-08-02 2004-02-05 Smithkline Beecham Corp. Endothelinrezeptorantagonist
US6417360B1 (en) * 1999-03-03 2002-07-09 Hoffmann-La Roche Inc. Heterocyclic sulfonamides
AU2001263850A1 (en) * 2000-04-20 2001-11-07 Actelion Pharmaceuticals Ltd Pyrimidine-sulfonamides having endothelin-antagonist activity

Also Published As

Publication number Publication date
EP1601361B1 (en) 2008-05-14
CN1756552A (zh) 2006-04-05
HRP20050860A2 (en) 2005-10-31
KR101099189B1 (ko) 2011-12-27
NO20054148L (no) 2005-09-06
ES2305737T3 (es) 2008-11-01
CY1108241T1 (el) 2013-09-04
WO2004078104A3 (en) 2004-10-28
ZA200507122B (en) 2006-05-31
JP2006519817A (ja) 2006-08-31
UA82087C2 (uk) 2008-03-11
NZ542155A (en) 2008-09-26
EP1601361A2 (en) 2005-12-07
PL1601361T3 (pl) 2008-10-31
AU2004216858B2 (en) 2009-07-16
BRPI0408082A (pt) 2006-02-14
SI1601361T1 (sl) 2008-10-31
PT1601361E (pt) 2008-07-29
US20060094731A1 (en) 2006-05-04
IL170626A (en) 2010-05-31
AU2004216858A1 (en) 2004-09-16
AU2009225323B2 (en) 2011-11-24
RS20050683A (en) 2007-11-15
CN100453081C (zh) 2009-01-21
JP4737686B2 (ja) 2011-08-03
WO2004078104A2 (en) 2004-09-16
EP1454625A1 (en) 2004-09-08
KR20050106083A (ko) 2005-11-08
DE602004013734D1 (de) 2008-06-26
MXPA05009478A (es) 2005-10-18
AU2009225323A1 (en) 2009-11-05
ATE395063T1 (de) 2008-05-15
ECSP056060A (es) 2006-01-27
US20090005404A1 (en) 2009-01-01
HK1083761A1 (en) 2006-07-14
CA2517930A1 (en) 2004-09-16
CA2517930C (en) 2011-04-26

Similar Documents

Publication Publication Date Title
DK1855677T3 (da) 3,11 B-CIS-dihydrotetrabanezin til behandling af skizofreni og andre psykoser
DK1487444T3 (da) Anvendelse af pyridylamider som angiogeneseinhibitorer
DK1940786T3 (da) Biphenylderivater og deres anvendelse ved behandling af hepatitis C
CY1112483T1 (el) Αγωνιστες gpcr πιπεριδινης
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
DE60230266D1 (de) Phenylpyridincarbonyl piperazinderivate
NO20062644L (no) DPP-IV inhibitorer
NO20082209L (no) Homo- og heterocykliske forbindelser anvendbare som CETP-inhibitorer
NO20082118L (no) Heterocykliske CETP-inhibitorer
NO20080265L (no) 2-(1H-indolylsulfanyl)-arylaminderivater
AR045959A1 (es) Derivados de pirazolo- e imidazo-pirimidina
TW200716571A (en) Heterocyclic reverse transcriptase inhibitors
EA200801366A1 (ru) Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина
CY1108241T1 (el) Πυριδυλσουλφοναμιδο πυριμιδινες για την θεραπεια της διαβητικης νεφροπαθειας
ATE308541T1 (de) 2-amino-4-heteroarylethyl-thiazolinderivate und ihre verwendung als hemmstoffe der induzierbaren no-synthase
GB0412314D0 (en) Compounds
DK1637141T3 (da) Stabiliseret proteasesammensætning omfattende en serinprotease, morpholinderivater og reversible inhibitorer af serinproteasen
DK1924255T3 (da) Anvendelse af N-(dibenz(B,F)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamin (OMIGAPIL) til profylakse og/eller behandling af muskeldystrofi
ATE338759T1 (de) 2-(aminomethyl)tetrahydro-9-oxa-1,3- diazacyclopentaca)naphthalinylderivate mit antipsychotischer wirkung
DK1421086T3 (da) 2-(Aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl-derivater med antipsykotisk aktivitet
TH82384A (th) อนุพันธ์แอริล 1,4-ไพราซินที่ถูกแทนที่
TH82384B (th) อนุพันธ์แอริล 1,4-ไพราซินที่ถูกแทนที่
ATE527267T1 (de) 1-ä2',3'-didesoxy-3'-c(hydroxymethyl)-b-d-eryth o-pentofuranosylü cytosinderivate als hiv- inhibitoren
TH94707B (th) สารประกอบอะมิโน-5-[4-(ไดฟลูออโรเมทธอกซี)ฟีนิล]-5-ฟีนิลอิมมิดาโซโลนสำหรับการยับยั้ง b ซีครีเตส
TH76971A (th) อนุพันธ์ไตรไซคลิกที่ถูกหลอม